The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?-Reference-Cited by-同舟云学术

The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?

Published:2003-08 Issue:2 Volume:47 Page:83-89
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Epstein Jonathan I.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference26 articles.

1. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder;Epstein;Am. J. Surg. Pathol.,1998

2. Papillary urothelial hyperplasia. A precursor to papillary neoplasms;Taylor;Am. J. Surg. Pathol.,1996

3. Prognostic significance of atypical papillary urothelial hyperplasia;Swierczinski;Hum Pathol,2002

4. Noninvasive papillary carcinoma of the bladder associated with carcinoma in-situ;Althausen;J. Urol.,1976

5. Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy;Farrow;Cancer Res.,1976

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proposal of a grading system for squamous cell carcinoma of the lung — the prognostic importance of tumour budding, single cell invasion, and nuclear diameter;Virchows Archiv;2023-08-09

2. Clinicopathological analysis of recurrence and progression of low-grade papillary urothelial carcinoma of the urinary bladder: Predicting the outcome;Annals of Diagnostic Pathology;2022-12

3. Obligate and Potential Precursors of Melanoma;JNCI: Journal of the National Cancer Institute;2022-08-31

4. Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification;International Journal of Molecular Sciences;2022-07-23

5. Evolving Treatment in Non-muscle-Invasive Bladder Cancer;Urologic Oncology;2022